{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:54:21Z","timestamp":1780343661828,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dsx.2026.103378","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:32:29Z","timestamp":1769844749000},"page":"103378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global assessment of insulin and oral hypoglycaemic agent accessibility and affordability: A cross-sectional survey of international diabetes federation member countries"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1114-5873","authenticated-orcid":false,"given":"Bishwajit","family":"Bhowmik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnima","family":"Siddiquee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayla Cdv.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1860-0621","authenticated-orcid":false,"given":"Abhimanyu S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2026.103378_bib1","series-title":"IDF diabetes atlas","year":"2021"},{"issue":"8","key":"10.1016\/j.dsx.2026.103378_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in Sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2026.103378_bib3","series-title":"WHO model list of essential medicines \u2013 22nd list","year":"2021"},{"issue":"12","key":"10.1016\/j.dsx.2026.103378_bib4","first-page":"1020","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"7","author":"Beran","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2026.103378_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002751","article-title":"Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys","volume":"16","author":"Manne-Goehler","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.dsx.2026.103378_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001410","article-title":"Insulin prices, availability and affordability in 13 low-income and middle-income countries","volume":"4","author":"Ewen","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"6","key":"10.1016\/j.dsx.2026.103378_bib7","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680,102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.dsx.2026.103378_bib8","series-title":"The Global diabetes compact: accelerating action on diabetes","year":"2021"},{"key":"10.1016\/j.dsx.2026.103378_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s13300-024-01568-9","article-title":"Barriers to the use of insulin therapy and potential solutions: a narrative review of perspectives from the Asia-Pacific region","volume":"15","author":"Chen","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.dsx.2026.103378_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3474","article-title":"Estimated sustainable cost-based prices for diabetes medicines","volume":"7","author":"Barber","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.dsx.2026.103378_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309350","article-title":"Availability, price and affordability of insulin, delivery devices and self-monitoring blood glucose devices in Indonesia","volume":"19","author":"Ramadaniati","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2026.103378_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11892-025-01588-0","article-title":"Financial toxicity in diabetes: the state of what we know","volume":"25","author":"Patel","year":"2025","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.dsx.2026.103378_bib13","series-title":"Access to medicines and supplies for people with diabetes","year":"2016"},{"key":"10.1016\/j.dsx.2026.103378_bib14","series-title":"Keeping the 100-year-old promise: making insulin access universal","year":"2021"},{"key":"10.1016\/j.dsx.2026.103378_bib15","series-title":"WHO insulin market report: global landscape and policy recommendations","year":"2021"},{"issue":"4","key":"10.1016\/j.dsx.2026.103378_bib16","first-page":"360","article-title":"Health outcome changes in individuals with type 1 diabetes after a state-level insulin copayment cap","volume":"184","author":"Giannouchos","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.dsx.2026.103378_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s13300-024-01556-z","article-title":"Expert opinion on current trends in the use of insulin in the management of people with type 2 diabetes from the south-eastern european region and Israel","volume":"15","author":"Tabak","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.dsx.2026.103378_bib18","article-title":"Trends and regional differences in antidiabetic medication use in Hungary","volume":"15","author":"Csatordai","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dsx.2026.103378_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-020-05375-2","article-title":"A global perspective on the issue of access to insulin","volume":"64","author":"Beran","year":"2021","journal-title":"Diabetologia"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:16:09Z","timestamp":1773317769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402126000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1871402126000056"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103378","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global assessment of insulin and oral hypoglycaemic agent accessibility and affordability: A cross-sectional survey of international diabetes federation member countries","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"103378"}}